GeoVax Labs, Inc.
GeoVax Labs, Inc., a clinical-stage biotechnology company, develops human vaccines and immunotherapies against infectious diseases and cancers using modified vaccinia ankara virus-like particle vaccine platform. It is developing various preventive vaccin…
Insiders
Transactions
| Reported Owner(s) | Position Now | Transaction Date | Type | Position Change | Extra | ||
|---|---|---|---|---|---|---|---|
|
$26,661
d
cs
10% Holder
|
08/09/24 |
P
|
8,000 x $1.95 = $15,600.00 |
Footnotes
|
|||
|
$18,661
d
cs
10% Holder
|
02/22/24 |
P
|
8,209 x $2.27 = $18,634.43 |
Footnotes
|
|||
|
$10,452
d
cs
10% Holder
|
02/21/24 |
P
|
520 x $2.15 = $1,118.00 |
Footnotes
|
|||
|
$7,213
d
cs
10% Holder
|
02/07/24 |
P
|
2,000 x $2.77 = $5,540.00 |
Footnotes
|
|||
|
$35,782
d
cs
10% Holder
|
12/22/23 |
P
|
6,944 x $0.36 = $2,499.84 |
Footnotes
|
|||
Get PRO Today
With PRO you will unlock 11 more insider transactions for GeoVax Labs, Inc.
Individuals
We summarize earnings call passages, compensations, insider transactions and other information for each individual to get the bigger picture:
- Chase Randal D Director
- Dodd David A President, CEO
- Kollintzas Dean G Director
- Lemerond Nicole Director
- Mckee Kelly T. Jr. Chief Medical Officer
- Mcnally Robert T Director
- Morgan Jayne Director
- Newman Mark J Chief Scientific Officer
- Reynolds Mark CFO
- Sharkey John W. VP, Business Development
- Spencer John N Jr Director
Individuals
We summarize earnings call passages, compensations, insider transactions and other information for each individual to get the bigger picture:
- Chase Randal D Director
- Dodd David A President, CEO
- Kollintzas Dean G Director
- Lemerond Nicole Director
- Mckee Kelly T. Jr. Chief Medical Officer
- Mcnally Robert T Director
- Morgan Jayne Director
- Newman Mark J Chief Scientific Officer
- Reynolds Mark CFO
- Sharkey John W. VP, Business Development
- Spencer John N Jr Director